“vaccines” Archives

Entry Author Date Location
Leprosy 2013 – The Problem and the Solutions 01/25/13 Seattle
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Seattle Biomed, Emerald Bio and Peers Get Big NIH Contract Extension 11/19/12 Seattle
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
Genocea Snags $30M from Gates Foundation, VCs for New Vaccines 10/10/12 Boston
Vaxxas Entices Merck to Try Needle-Free Vaccine Technique 10/08/12 Boston
We Have To Do Better on TB, In King County and High-Burden Countries 09/24/12 Seattle
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
Life Sciences Discovery Fund Gets New Leader, A Familiar Face 07/03/12 Seattle
Building Bridges in a New Global Health Landscape 06/04/12 Seattle
IDRI, Aeras Team Up to Develop Tuberculosis Vaccine 05/09/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
Harvard-Born TremRx Pursues New Vaccine Technology 02/29/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine 12/09/11 Detroit Ann Arbor
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation 10/31/11 Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech 10/27/11 New York
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme 10/26/11 National
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question 10/19/11 Seattle
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine 10/18/11 Boston
Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science 10/13/11 Seattle
Page 3 of 10 « previous page · next page »